Beijing Aosaikang Pharmaceutical Co., Ltd.

XSEC:002755 Stock Report

Market Cap: CN¥12.6b

Beijing Aosaikang Pharmaceutical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Jingfei Ma

Chief executive officer

CN¥900.0k

Total compensation

CEO salary percentagen/a
CEO tenure3.4yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure6yrs

Recent management updates

Recent updates

CEO

Jingfei Ma (36 yo)

3.4yrs

Tenure

CN¥900,000

Compensation

Mr. Jingfei Ma is GM & Director of Beijing Aosaikang Pharmaceutical Co., Ltd. from February 18, 2022 and has been its Company Secretary since September 30, 2021.

Board Members

NamePositionTenureCompensationOwnership
Jingfei Ma
GM, Board Secretary & Director3yrsCN¥900.00kno data
Youyin Xu
Deputy GM & Director6yrsCN¥2.00mno data
Xiaoming Wu
Independent Director6yrsCN¥100.00kno data
Qingcai Chen
Chairmanno dataCN¥1.89mno data
Jianwen Liu
Independent Director6yrsCN¥100.00kno data
Xiangfeng Chen
Non-Independent Director6yrsCN¥1.00mno data
Di Li
Independent Director6yrsCN¥100.00kno data
Jing Chen
Chairman of the Supervisory Board6yrsno datano data
Xiaowen Wang
Non-Independent Director3yrsCN¥670.00k0.00078%
CN¥ 98.5k
Suling Zhou
Non-Independent Director3.8yrsno datano data
Yanrong Zhao
Employee Supervisor3yrsno data0.00048%
CN¥ 60.6k
Hong Fang Xue
Employee Supervisor3yrsno datano data

6.0yrs

Average Tenure

56yo

Average Age

Experienced Board: 002755's board of directors are considered experienced (6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/05 04:42
End of Day Share Price 2025/02/05 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Beijing Aosaikang Pharmaceutical Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shitong HanCitic Securities Co., Ltd.
Yinhao TangCitic Securities Co., Ltd.
Wei ZhengTianfeng Securities Brokerage Co., Ltd